Product Introduction:
Glimisave MV Tablet combines Glimepiride (0.3 mg), Metformin Hydrochloride (500 mg), and Voglibose (2 mg). Glimepiride stimulates insulin secretion, Metformin decreases glucose production in the liver, and Voglibose slows carbohydrate absorption, together helping in effective blood sugar control.
Uses:
-
Management of type 2 diabetes mellitus
-
Control of high blood sugar levels
-
Used when diet, exercise, and single drug therapy are insufficient
Benefits:
-
Provides better glycemic control through multiple pathways
-
Helps reduce fasting and postprandial blood glucose
-
May help in preventing diabetes-related complications
-
Improves insulin sensitivity and glucose utilization
Composition:
-
Glimepiride 0.3 mg
-
Metformin Hydrochloride 500 mg
-
Voglibose 2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal upset (nausea, diarrhea)
-
Dizziness or headache
-
Rare allergic reactions
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood sugar regularly
-
Inform your doctor if pregnant, breastfeeding, or with kidney/liver issues
-
Avoid alcohol while on medication
-
Do not skip doses or stop medication without consulting your healthcare provider
